Canopy Growth Corp (CGC) stock
CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
$0.50−0.03 (-5.63%)
Close on Nov 18, 2026Market cap $212.15MP/E –Yield –
Canopy Growth r&d expenses
Research and development expenses are spending on new products and technology.
Canopy Growth's R&D Expenses for the twelve months ending Mar 31, 2021 was C$57.58M. For fiscal 2026 it was C$2.61M, down 4.7% from the year before. The highest annual figure on record is C$61.81M in fiscal 2020.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | C$2.61M | -4.7% |
| FY2025 | Mar 31, 2025 | C$2.74M | -40.5% |
| FY2024 | Mar 31, 2024 | C$4.61M | -78.8% |
| FY2023 | Mar 31, 2023 | C$21.72M | -32.7% |
| FY2022 | Mar 31, 2022 | C$32.26M | -44.0% |
| FY2021 | Mar 31, 2021 | C$57.58M | -6.8% |
| FY2020 | Mar 31, 2020 | C$61.81M | +305.6% |
| FY2019 | Mar 31, 2019 | C$15.24M | +642.2% |
| FY2018 | Mar 31, 2018 | C$2.05M | +153.5% |
| FY2017 | Mar 31, 2017 | C$810.00K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | C$57.58M | – |
See a number that looks wrong?